The report describes an investigation in which failures to replicate the proposed association between the dopamine D4 receptor gene (DRD4) exon III polymorphism and Novelty Seeking are in part due to the action of additional modulating genetic variants. The results clearly support the hypothesis of Benjamin and associates that in the presence of the long 5-HTTLPR allele and in the presence of the COMT val/val genotype, Novelty Seeking scores are higher in carriers of the DRD4 exon III 7 repeat allele.
SCIENTIFIC CORRESPONDENCE
Further evidence for a modulation of Novelty Seeking by DRD4 exon III, 5-HTTLPR, and COMT val/met variants A Strobel, KP Lesch, S Jatzke, F Paetzold, B Brocke
The report describes an investigation in which failures to replicate the proposed association between the dopamine D4 receptor gene (DRD4) exon III polymorphism and Novelty Seeking are in part due to the action of additional modulating genetic variants. The results clearly support the hypothesis of Benjamin and associates that in the presence of the long 5-HTTLPR allele and in the presence of the COMT val/val genotype, Novelty Seeking scores are higher in carriers of the DRD4 exon III 7 repeat allele.
FEATURE ARTICLE
Glutamatergic mechanisms in addiction TM Tzschentke, WJ Schmidt Recent research has shown that glutamate plays an important role in processes that contribute to the development and maintenance of addiction. In many cases, the involvement of glutamate relates to its interaction with dopamine, while in other cases the actions of glutamate may be independent of dopaminergic mechanisms. This review summarizes recent findings regarding the role of glutamate in addiction and attempts to integrate these findings into currently discussed models of addiction.
REVIEW ARTICLE
Psychotic symptoms in Alzheimer's disease: evidence for a distinct phenotype RA Sweet, VL Nimgaonkar, B Devlin, DV Jeste
In this review, the authors evaluate the hypothesis that psychotic symptoms, such as delusions and hallucinations, define a suitable subphenotype in Alzheimer disease patients for gene mapping efforts. Psychotic symptoms occur in 40-60% of patients with Alzheimer's disease (AD) and are associated with more severe cognitive deficits and a more rapidly deteriorating course. Candidate gene association analyses and initial linkage analysis have yielded significant results. The authors discuss possible genetic models of psychotic symptoms in AD and suggest strategies for further investigation.
ORIGINAL RESEARCH ARTICLES
The dopamine transporter gene is associated with attention-deficit hyperactivity disorder in a Taiwanese sample
Several studies have reported association between attention-deficit hyperactivity disorder (ADHD) and the 10-repeat allele of a 40-bp VNTR polymorphism that lies within the 3 0 -UTR of DAT1. The authors have analyzed the DAT1 polymorphism in a sample of 110 Taiwanese probands with a DSM-IV diagnosis of ADHD and found evidence of increased transmission of the 10-repeat allele using TRANSMIT (c2 ¼ 10.8, 1 d.f., P ¼ 0.001, OR ¼ 2.9, 95% CI 1.4-6.3). These data gave rise to an odds ratio similar to that observed in previous studies of Caucasian individuals, despite a far higher frequency of the risk allele.
Candidate genes for anorexia nervosa in the lp33-36 linkage region: serotonin ID and delta opioid receptors display significant association to anorexia nervosa
The genes for the serotonin ID receptor (HTR1D) and the opioid delta receptor (OPRD1) are found on Chr1p 36.3-34.3, a region identified by the authors in a linkage analysis of anorexia nervosa (AN). Statistically significant genotypic, allelic and haplotypic association to AN in the case : control design was observed at HTR1D and OPRD1, with effect sizes for individual SNPs of 2.63 (95% CI ¼ 1.21-5.75) for HTR1D and 1.61 (95% CI ¼ 1.11-2.44) for OPRD1. Using genotype data on parents and AN probands, three SNPs at HTR1D were found to exhibit significant transmission disequilibrium (po0.05).
Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid b-peptide-induced cholinergic dysfunction MH Tran, K Yamada, A Nakajima, M Mizuno, J He, H Kamei, T Nabeshima Amyloid b (Ab) is a critical factor involved in the pathogenesis of Alzheimer's disease (AD). The authors demonstrated that chronic intracerebroventricular infusion of Ab in rats caused a robust peroxynitrite formation and subsequent tyrosine nitration of synaptophysin, a synaptic protein involved in the neurotransmitter release. Treatment with an inducible nitric oxide synthase inhibitor or a peroxynitrite scavenger prevented tyrosine nitration of synaptophysin as well as Ab-induced impairment of acetylcholine release.
Islet-brain I/c-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer's disease N Helbecque, A Abderrhamani, L Meylan, B Riederer, V Mooser, J Miklossy, J Delplanque, P Boutin, P Nicod, J-A Haefliger, D Cottel, P Amouyel, P Froguel, G Waeber
The authors identified a À499A4G polymorphism in the 5 0 regulatory region of the MAPK8IP1 gene, which alone was not associated with an increased risk to Alzheimer's disease (AD) in two separate French populations. However, this polymorphism was strongly associated with AD in subjects bearing the CC genotype in the lipoprotein receptor-related protein (LRP) gene. In in vitro studies, the G allele increased transcriptional activity in neuronal cells. Therefore, the increased transcriptional activity in the presence of the G allele of MAPK8IP1 is probably a risk factor for the onset of AD in patients bearing the CC genotype of the LRP gene.
Depressive-like behavior and stress reactivity are independent traits in a Wistar-Kyoto Â Fisher 344 cross LC Solberg, N Ahmadiyeh, AE Baum, MH Vitaterna, JS Takahashi, FW Turek, EE Redei Through reciprocal breeding of Wistar-Kyoto (WKY) and Fisher 344 (F344) parent strains and brothersister breeding of the Fl generation, the authors obtained 486 F2 animals. Parent, Fl and F2 animals were tested in the forced swim test (FST). Blood samples were collected for determination of basal and stress (10-min restraint) plasma corticosterone (CORT) levels, and adrenal weights were measured. The authors found that all measures were heritable to some extent and were highly sex-dependent. FST behavior and HPA axis measures were not directly related.
Developmentally regulated and psychostimulant-inducible novel rat gene mrt1 encoding PDZ-PX proteins isolated in the neocortex Y Kajii, S Muraoka, S Hiraokal, K Fujiyama, A Umino, T Nishikawa
This study isolates a developmentally regulated and methamphetamine-inducible novel rat gene, mrt1 (methamphetamine-responsive transcript 1), encoding PDZ-PX proteins in the neocortex. Methamphetamine-induced changes in neocortical expression of a major type of mrt1 splicing variants exhibit a late developing, cocaine-crossreactive, Dl dopamine receptor-dependent and long-term nature. These pharmacological profiles are shared by psychostimulant-induced behavioral sensitization, a useful model of schizophrenia-like psychosis or drug craving in psychostimulant abuse. Therefore, mrt1 is a candidate molecule that is involved in addiction to psychostimulants and/or age-related onset of other mental dysfunctions such as schizophrenia.
Linkage of schizophrenia with chromosome 1q loci in Taiwanese families H-G Hwu, C-M Liu, CS-J Fann, W-C Ou-Yang, SF-C Lee Using linkage analysis on 52 Taiwanese families, this study found that the markers D1S1679 and D1S251 in the chromosome regions 1q22-31 and 1q42-44, respectively, had evidence of linkage with schizophrenia. Markers D1S1679 and D1S251 had a significant proportion (0.57, p ¼ 0.03) of shared identity by descent and maximal NPL scores of 2.18 (p ¼ 0.01), respectively. These findings may provide guidance for positional cloning studies on candidate genes in the 1q22-31 and 1q41-44 regions.
Extrastriatal dopamine D2/3 receptor density and distribution in drug-naive schizophrenic patients H Tuppurainen, J Kuikka, H Viinamäki, M Husso-Saastamoinen, K Bergström, J Tiihonen
The authors studied the extrastriatal D2/3 receptor binding with a novel SPET ligand epidepride in seven drug-naive schizophrenic patients and seven matched controls. The findings indicated an extremely low binding among patients in temporal cortex in both hemispheres when compared with controls, and the D2/3 levels had negative correlations with general psychopathological and negative schizophrenic symptoms. These results support the previous hypothesis on dysfunction of mesocortical dopamine function behind the cognitive and negative symptoms in schizophrenia.
